Matches in Wikidata for { <http://www.wikidata.org/entity/Q104484526> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q104484526 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 16ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104484526 description "article scientifique publié en 2020" @default.
- Q104484526 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104484526 description "scientific article published on 16 December 2020" @default.
- Q104484526 description "wetenschappelijk artikel" @default.
- Q104484526 description "наукова стаття, опублікована 16 грудня 2020" @default.
- Q104484526 name "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 name "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 name "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 type Item @default.
- Q104484526 label "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 label "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 label "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 prefLabel "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 prefLabel "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 prefLabel "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 P1433 Q104484526-32278702-664A-4529-9CA8-801C95E97966 @default.
- Q104484526 P1476 Q104484526-38247E69-F928-4003-9AE5-336EED1A6B21 @default.
- Q104484526 P2093 Q104484526-A6C96C9D-94DE-4E29-8878-4B135036EDEF @default.
- Q104484526 P31 Q104484526-E6209225-2DFF-4E8B-A31C-CAF78139A27B @default.
- Q104484526 P356 Q104484526-CFE5C421-4193-41E0-A14B-49DF26C70851 @default.
- Q104484526 P577 Q104484526-625DF2DE-B7F7-43D6-B4F5-916C7537E704 @default.
- Q104484526 P698 Q104484526-EA9F7E94-DCFC-4CB7-89E8-8738A83EC099 @default.
- Q104484526 P921 Q104484526-57EDD350-3464-401C-A92F-8CD96AF386C2 @default.
- Q104484526 P356 IJU.14470 @default.
- Q104484526 P698 33327040 @default.
- Q104484526 P1433 Q15767019 @default.
- Q104484526 P1476 "Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study" @default.
- Q104484526 P2093 "Shinichi Sakamoto" @default.
- Q104484526 P31 Q13442814 @default.
- Q104484526 P356 "10.1111/IJU.14470" @default.
- Q104484526 P577 "2020-12-16T00:00:00Z" @default.
- Q104484526 P698 "33327040" @default.
- Q104484526 P921 Q181257 @default.